According to GlobalData’s medical device pipeline database, 739 Digital Therapeutics devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 649 are in active development, while the remaining 101 are in an inactive stage of development. There are 390 products in the early stages of development, and the remaining 259 are in the late stages of development.

Digital therapeutics DTx are a subset of digital health interventions that employ software-driven, evidence-based therapeutic interventions to prevent, manage, or treat medical disorders. Unlike general health apps that focus on wellness and fitness, DTx are designed to deliver specific therapeutic interventions and achieve clinically meaningful outcomes. These interventions often mimic conventional medical treatments but are delivered through software applications. DTx can target a broad spectrum of conditions, including mental health disorders, chronic diseases, and neurological conditions.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Digital Therapeutics pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Digital Therapeutics devices. Overall, most of these Digital Therapeutics pipeline devices are being developed by private entities.

Key players involved in the active development of Digital Therapeutics include Alex Therapeutics, Brainaurora Medical Technology, Click Therapeutics, Pear Therapeutics, Arcade Therapeutics, Aimmed, daVinci Digital Therapeutics, Lumos Labs, LUCA Healthcare Ltd and MindMaze.

For a complete picture of the developmental pipeline for Digital Therapeutics devices, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.